A dual drug therapy for sunitinib resistant RCC: An in vitro analysis.

Jacob W. Greenberg,Hogyoung Kim,Ahmed A. Moustafa,Pedro C. Barata,Asim B. Abdel-Mageed,L. Spencer Krane

A dual drug therapy for sunitinib resistant RCC: An in vitro analysis.

2021

Jacob W. Greenberg
Hogyoung Kim
Ahmed A. Moustafa
Pedro C. Barata
Asim B. Abdel-Mageed
L. Spencer Krane

340Background: Over the last decade, medical treatment for metastatic renal cell carcinoma has made significant advances through the development of tyrosine kinase inhibitors (TKI) like sunitinib. ...

Keywords:

Cancer research
medical treatment
in vitro analysis
Renal cell carcinoma
Pharmacotherapy
Sunitinib
Medicine
Tyrosine kinase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations